<DOC>
	<DOCNO>NCT01422681</DOCNO>
	<brief_summary>The minimally invasive extracorporeal carbon dioxide removal may decrease respiratory load chronic obstructive pulmonary disease ( COPD ) exacerbation , reduce need advance respiratory care toward invasive mechanical ventilation patient refractory non-invasive ventilatory support ( NIV ) , decrease need ventilatory support patient already invasively ventilate , thereby accelerate wean process . The investigator intend perform multi-center experimental non randomize single arm prospective study investigate efficacy Decap Smart reduce intubation rate duration invasive mechanical ventilation patient COPD treat either NIV invasive mechanical ventilation ( IMV ) severe respiratory failure hypercapnia . The result study compare data available literature .</brief_summary>
	<brief_title>Extracorporeal CO2 Removal COPD Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>COPD severe acute respiratory failure least two hour continuous application noninvasive ventilatory support ( NIV ) : arterial pH ≤7.30 arterial pressure CO2 ( PaCO2 ) &gt; 20 % baseline value one following : respiratory rate ≥30 breaths/min ; use accessory muscle paradoxical abdominal movement failure obtain consent hemodynamic instability ( MAP &lt; 60 mmHg ) despite infusion vasoactive drug contraindication administration i.v . heparin ( heparin induce thrombocytopenia , hemorrhage , etc . ) body weight &gt; 120 kg contraindication continuation active treatment ( DNR )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>COPD</keyword>
</DOC>